Cover Image

Editorial: Computational chemogenomics: In silico tools in pharmacological research and drug discovery

Saved in:

Bibliographic Details
Main Authors:	Norberto Sánchez-Cruz (Author), Eli Fernandez-de Gortari (Author), José L. Medina-Franco (Author)
Format:	Book
Published:	Frontiers Media S.A., 2023-03-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Editorial: Insights in silico methods and artificial intelligence for drug discovery: 2022
by: José L. Medina-Franco
Published: (2023)

In silico repositioning-chemogenomics strategy identifies new drugs with potential activity against multiple life stages of Schistosoma mansoni.
by: Bruno J Neves, et al.
Published: (2015)

Correction: In Silico Repositioning-Chemogenomics Strategy Identifies New Drugs with Potential Activity against Multiple Life Stages of Schistosoma mansoni.
by: PLOS Neglected Tropical Diseases Staff
Published: (2015)

Chemogenomics Knowledgebased Polypharmacology Analyses of Drug Abuse Related G-Protein Coupled Receptors and Their Ligands
by: Xiang-Qun eXie, et al.
Published: (2014)

Editorial: Brief research reports in experimental pharmacology and drug discovery: 2022
by: Tahsin Hassan, et al.
Published: (2023)

Editorial: Insights in renal pharmacology: 2021
by: Norberto Perico, et al.
Published: (2022)

Editorial: Recent trends in anti-cancer drug discovery by in silico methods
by: Carmen Cerchia, et al.
Published: (2024)

Target Identification of Mycobacterium tuberculosis Phenotypic Hits Using a Concerted Chemogenomic, Biophysical, and Structural Approach
by: Grace Mugumbate, et al.
Published: (2017)

Editorial of Special Column on Antiviral Drug Discovery and Pharmacology
by: Jun Wang, et al.
Published: (2022)

Editorial: Insights in experimental pharmacology and drug discovery: 2022
by: Alexandra Latini, et al.
Published: (2023)

Editorial: Women in experimental pharmacology and drug discovery: 2021
by: Tea Lanišnik Rižner, et al.
Published: (2022)

Editorial: Insights in Experimental Pharmacology and Drug Discovery: 2021
by: Andres Trostchansky, et al.
Published: (2022)

Editorial: Women in experimental pharmacology and drug discovery 2023
by: Patricia Rijo, et al.
Published: (2024)

Editorial: Experimental and computational aspects of bioactive proteins from animal venoms: an insight into pharmacological properties and drug discovery
by: Michelle Khai Khun Yap, et al.
Published: (2024)

New Approaches for the Discovery of Pharmacologically-Active Natural Compounds
by: Medina-Franco, José L.
Published: (2019)

Integrative chemogenomic analysis identifies small molecules that partially rescue ΔF508‐CFTR for cystic fibrosis
by: Rachel A. Hodos, et al.
Published: (2021)

Editorial: Spotlight on artificial intelligence in experimental pharmacology and drug discovery
by: Verena Schöning, et al.
Published: (2023)

Editorial: Methods and application in experimental pharmacology and drug discovery: 2021
by: Letizia Polito, et al.
Published: (2022)

Editorial: Model organisms in experimental pharmacology and drug discovery 2022
by: Firzan Nainu, et al.
Published: (2023)

In Silico Methods for Drug Design and Discovery
Published: (2020)

Computational drug discovery of potential TAU protein kinase I inhibitors using in silico docking studies
by: Arumugam Madeswaran, et al.
Published: (2013)

Editorial: Metabolomics as a tool in ethnobotany-driven drug discoveries
by: Nokwanda Makunga, et al.
Published: (2022)

In Silico Study of Ceftaroline's Molecular Properties
by: Elso Manuel Cruz Cruz, et al.
Published: (2011)

In Silico Study of Ceftaroline's Molecular Properties
by: Elso Manuel Cruz Cruz, et al.
Published: (2011)

Excellence paves the way with current research in pharmacology and drug discovery
by: Luigino Calzetta, et al.
Published: (2020)

Editorial: Use of computational tools for designing epigenetic drugs
by: Yudibeth Sixto-López, et al.
Published: (2024)

Editorial: What does experimental pharmacology and drug discovery look like in 2035?
by: Maria Serena Fabbrini, et al.
Published: (2024)

Editorial: Molecular pharmacological approaches against lung diseases: targeted drug discovery
by: Poonam Arora, et al.
Published: (2024)

Editorial: Tumour microenvironment in cancer research and drug discovery
by: Nur Akmarina B. M. Said, et al.
Published: (2024)

Inhibitors of DNA Methyltransferases From Natural Sources: A Computational Perspective
by: Fernanda I. Saldívar-González, et al.
Published: (2018)

Identification of NAPRT Inhibitors with Anti-Cancer Properties by In Silico Drug Discovery
by: Moustafa S. Ghanem, et al.
Published: (2022)

Toxins in Drug Discovery and Pharmacology
by: Steve Peigneur (Ed.)
Published: (2018)

Curso atípico o incompleto de la enfermedad de Kawasaki en edades pediátricas
by: Norberto Sotelo-Cruz
Published: (2016)

Editorial: Advances in novel pharmacotherapeutics and drug discovery: computational, experimental, translational, and clinical models
by: Cristian Sandoval, et al.
Published: (2024)

Opportunities and Challenges for In Silico Drug Discovery at Delta Opioid Receptors
by: Yazan J. Meqbil, et al.
Published: (2022)

Editorial: MSPP 34th scientific meeting: Pharmacological perspectives on natural products in drug discovery
by: Mohd. Farooq Shaikh, et al.
Published: (2022)

Editorial: Model organisms in experimental pharmacology and drug discovery 2023: rodent, worm and zebrafish models
by: Kuo-Hui Su, et al.
Published: (2024)

Editorial: Computational and Experimental Approaches in Multi-target Pharmacology
by: Thomas J. Anastasio
Published: (2017)

Application of Computing as a High-Practicability and -Efficiency Auxiliary Tool in Nanodrugs Discovery
by: Ke Xu, et al.
Published: (2023)

Computational strategies for PROTAC drug discovery
by: Jia Wu, et al.
Published: (2023)